There are currently 623 clinical trials in Austin, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including GSK Investigational Site, Dell Childrens Medical Center of Central Texas, Pfizer Investigational Site and University of Texas at Austin. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Exploring the Nature, Assessment and Treatment of Stuttering
NCT05908123
Recruiting
The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.
Gender:
ALL
Ages:
Between 2 years and 85 years
Trial Updated:
06/20/2023
Locations: Arthur M. Blank Center for Stuttering Education and Research, Austin, Texas
Conditions: Stuttering, Stuttering, Adult, Stuttering, Childhood, Stuttering, Developmental
Register for Updates
Implementing a Church-based Parenting Intervention for Hispanics
NCT05291481
Recruiting
The current investigation consists of the implementation and modest refinements of a culturally adapted version of the evidence-based PT intervention known as GenerationPMTO.© The adapted intervention, CAPAS-Youth, is primarily delivered to parents. The primary research objectives are twofold: a) to conduct refinements of the CAPAS-Youth intervention for Hispanic immigrants in mid-Texas, and b) to measure implementation barriers and precursors, as well as implementation outcomes, in an effort to... Read More
Gender:
ALL
Ages:
12 years and above
Trial Updated:
06/14/2023
Locations: Steve Hicks School of Social Work, the University of Texas at Austin, Austin, Texas
Conditions: Adolescent Behavior, Parenting
Register for Updates
Impact of Customized Respiratory Training on Cardiopulmonary Function in Parkison's Disease
NCT05287243
Recruiting
People with PD have lower cardiopulmonary function than their age matched peers. This decline can further impair a person's ability to participate in exercise and daily activities. Furthermore, the limitations in cardiopulmonary function can have a severe impact on mortality. There is evidence indicating the positive changes IMT can have on cardiopulmonary function in people with PD. Through intensive daily exercise people with PD have shown improvements in maximum inspiratory pressure and maxi... Read More
Gender:
ALL
Ages:
Between 30 years and 99 years
Trial Updated:
05/08/2023
Locations: University of St. Augustine for Health Sciences, Austin, Texas
Conditions: Parkinson Disease
Register for Updates
Seaweed-derived Rhamnan Sulfate and Vascular Function
NCT05651230
Recruiting
The primary aim of the proposed investigation is to examine the hypothesis that a relatively short period of rhamnan sulfate supplementation would improve key markers of vascular dysfunction in middle-aged and older adults with at least one risk factors for cardiovascular disease.
Gender:
ALL
Ages:
Between 35 years and 85 years
Trial Updated:
05/08/2023
Locations: Cardiovascular Aging Research Lab at UT Austin, Austin, Texas
Conditions: Cardiovascular Diseases
Register for Updates
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
NCT05401357
Recruiting
This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioequivalence with clinical endpoint in subjects with chronic open-angle glaucoma or ocular hypertension in both eyes. Test Product - Bimatoprost ophthalmic solution, 0.01% of Amneal EU, Limited Reference Product - LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of Allergan, Inc.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/09/2022
Locations: Keystone Research, Austin, Texas
Conditions: Glaucoma, Open-Angle, Ocular Hypertension
Register for Updates
A Study in Patients With Advanced Cancers
NCT05320588
Recruiting
A first-in-human study using BIO-106 as a single agent and in combination with pembrolizumab in advanced cancers.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/15/2022
Locations: NEXT Oncology Austin, Austin, Texas
Conditions: Advanced Cancer, Advanced Solid Tumor, Cancer, Oncology
Register for Updates
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
NCT03082755
Recruiting
Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsychotics. Effective treatments are lacking because of limited knowledge of the etiology of nighttime agitation. The investigators propose a clinical trial to better elucidate whether a sleep disorder, restless legs syndrome, may be a mechanism for nighttime agitation, and if treatment with gabapentin enacarbil (Horizant®) reduces nighttime... Read More
Gender:
ALL
Ages:
55 years and above
Trial Updated:
05/16/2022
Locations: The University of Texas at Austin, Austin, Texas
Conditions: Alzheimer Disease
Register for Updates
Neuroimaging Memories of Fear and Safety in the Human Brain
NCT04975009
Recruiting
The purpose of this research is to use functional magnetic resonance imaging (fMRI) to investigate how the brain forms associations between neutral and negative stimuli. The ultimate goal is to understand the neural systems involved in regulating negative emotional responses to fearful stimuli.
Gender:
ALL
Ages:
Between 18 years and 50 years
Trial Updated:
05/16/2022
Locations: The University of Texas at Austin, Austin, Texas +1 locations
Conditions: Fear Anxiety, PTSD
Register for Updates
Registry and Biorepository for IBD in Central Texas
NCT04617184
Recruiting
This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or end... Read More
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
05/13/2021
Locations: Dell Medical School, UT Austin, Austin, Texas
Conditions: Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Register for Updates
Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia
NCT04519099
Recruiting
To evaluate the efficacy and safety of cariprazine at a target dose of 4.5 mg/d compared with placebo in prevention of relapse in patients with schizophrenia To evaluate the efficacy and safety of cariprazine at a target dose of 3.0 mg/d compared with placebo in prevention of relapse in patients with schizophrenia who were initially stabilized on a target dose of 4.5 mg/d
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
08/17/2020
Locations: Community Clinical Research, Inc., Austin, Texas
Conditions: Schizophrenia
Register for Updates
Cerclage for Twins With Short Cervical Length ≤ 15mm
NCT03340688
Recruiting
This is a multicenter randomized study designed to determine if ultrasound indicated cerclage reduces the incidence of spontaneous preterm birth \<34 weeks in asymptomatic women with twin gestations and cervical length ≤15mm, diagnosed by transvaginal ultrasound between 16 to 23 6/7 weeks of gestation.
Gender:
FEMALE
Ages:
Between 18 years and 60 years
Trial Updated:
04/23/2020
Locations: Austin Maternal Fetal Medicine St David's Health Care, Austin, Texas
Conditions: Twin Pregnancy With Antenatal Problem, Preterm Birth, Short Cervix
Register for Updates